{"raw_mentions": "Since there are no sentences that contain all four required components (molecule name, bioactivity metric, numeric value, and unit) in the provided text snippet, I will return no sentences. The text primarily describes methods, compositions, and figures without providing specific bioactivity metrics with numeric values and units."}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain any sentences with a specific molecule name, bioactivity metric, numeric value, and unit."}
{"raw_mentions": "The term \u201cimmunospecific\u201d or \u201cspecifically binding\u201d means that the antibody binds to the coagulation factor XI and/or its activated form, the coagulation factor XIa with an affinity K<sub>D </sub>of lower than or equal to 10<sup>\u22126</sup>M (monovalent affinity).\nThe term \u201chigh affinity\u201d means that the <sub>KD </sub>that the antibody binds to the coagulation factor XI and/or its activated form, the coagulation factor XIa with an affinity K<sub>D </sub>of lower than or equal to 10<sup>\u22127</sup>M (monovalent affinity)."}
{"final_json": [{"molecule_name": null, "protein_target_name": "coagulation factor XI and/or its activated form, the coagulation factor XIa", "binding_metric": "Kd", "value": "<=10^-6", "unit": "M", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "coagulation factor XI and/or its activated form, the coagulation factor XIa", "binding_metric": "Kd", "value": "<=10^-7", "unit": "M", "is_logarithmic": false}]}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain specific molecule names, bioactivity metrics, numeric values, and units as required."}
{"raw_mentions": "The pharmaceutical composition may be provided as a lyophilized powder in 1 mM-50 mM histidine, 0.1%-2% sucrose, 2%-7% mannitol at a pH range of 4.5 to 5.5 that is combined with buffer prior to use.\nAccording to the FDA, IC50 represents the concentration of a compound that is required for 50% inhibition of a given biological process. \nThe antibodies of the present invention exhibit IC50 values 100 \u03bcM, preferably 1 \u03bcM, more preferred 0.1 \u03bcM, more preferred 0.01 \u03bcM, more preferred 0.001 \u03bcM, more preferred 0.0001 \u03bcM."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "binding_metric": null, "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "IC50", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "antibodies", "protein_target_name": null, "binding_metric": "IC50", "value": "100 \u03bcM", "unit": "\u03bcM", "is_logarithmic": false}, {"molecule_name": "antibodies", "protein_target_name": null, "binding_metric": "IC50", "value": "1 \u03bcM", "unit": "\u03bcM", "is_logarithmic": false}, {"molecule_name": "antibodies", "protein_target_name": null, "binding_metric": "IC50", "value": "0.1 \u03bcM", "unit": "\u03bcM", "is_logarithmic": false}, {"molecule_name": "antibodies", "protein_target_name": null, "binding_metric": "IC50", "value": "0.01 \u03bcM", "unit": "\u03bcM", "is_logarithmic": false}, {"molecule_name": "antibodies", "protein_target_name": null, "binding_metric": "IC50", "value": "0.001 \u03bcM", "unit": "\u03bcM", "is_logarithmic": false}, {"molecule_name": "antibodies", "protein_target_name": null, "binding_metric": "IC50", "value": "0.0001 \u03bcM", "unit": "\u03bcM", "is_logarithmic": false}]}
